Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Licenses Prenatal Genetic Screening IP From Isis

NEW YORK (GenomeWeb News) — Sequenom today said it has licensed Isis Innovation’s intellectual property for non-invasive prenatal genetic testing.
 
Under the agreement, Sequenom licensed rights for Isis’s non-invasive prenatal diagnostic testing on nucleic acids derived from maternal plasma or serum, the company said.
 
Isis is Oxford University’s technology transfer company. It works to develop and market commercial applications for intellectual property owned by the school.
 
Financial terms of the agreement were not released.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.